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Abstract
Parkinson’s disease (PD)-associated Pink1 and Parkin proteins are
believed to function in a common pathway controlling mitochondrial
clearance and trafficking. Glial cell line-derived neurotrophic factor
(GDNF) and its signaling receptor Ret are neuroprotective in toxin-
based animalmodels of PD. However, themechanism bywhich GDNF/
Ret protects cells from degenerating remains unclear. We investi-
gated whether the Drosophila homolog of Ret can rescue Pink1 and
parkmutant phenotypes. We report that a signaling active version of
Ret (RetMEN2B) rescues muscle degeneration, disintegration of mito-
chondria and ATP content of Pink1mutants. Interestingly, correspond-
ing phenotypes of park mutants were not rescued, suggesting that
the phenotypes of Pink1 and park mutants have partially different
origins. In human neuroblastoma cells, GDNF treatment rescues mor-
phological defects of PINK1 knockdown, without inducing mitophagy
or Parkin recruitment. GDNF also rescues bioenergetic deficits of PINK
knockdown cells. Furthermore, overexpression of RetMEN2B signifi-
cantly improves electron transport chain complex I function in Pink1
mutant Drosophila. These results provide a novel mechanism underly-
ing Ret-mediated cell protection in a situation relevant for human PD.
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Introduction
The etiology of Parkinson’s Disease (PD) is highly complex and
largely unknown, involving both environmental and genetic risk
factors. Mitochondrial dysfunction, oxidative stress and protein
aggregation are believed to be central events in the pathological
process, but their interconnection remains unclear (Schapira &
Jenner, 2011; Exner et al, 2012; McCoy & Cookson, 2012). The first
indications of a role for mitochondria came with the discovery that
the toxin 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine (MPTP)
causes Parkinsonism in humans and animal models (Burns et al,
1983; Langston et al, 1983). Its active metabolite, 1-methyl-4-phenyl-
pyridinium ion (MPP+), is selectively imported into dopaminergic
neurons via the dopamine transporter, and inhibits complex I of the
electron transport chain (ETC). Several other mitochondrial toxins,
including paraquat and rotenone, generating either mitochondrial
reactive oxygen species (ROS) or specifically inhibiting complex I,
have been linked to PD in epidemiological studies and animal
models (de Lau & Breteler, 2006). Furthermore, patients with
sporadic PD can have decreased activity of complex I in brain and
other tissues (Schapira et al, 1989; Parker & Swerdlow, 1998), or
less complex I proteins in the substantia nigra (Mizuno et al, 1989).
Autosomal recessive PD-associated proteins Parkin, PINK1 and
DJ-1 (OMIM #600116, 605909, 606324) have been shown to have
functions related to mitochondrial integrity, (reviewed in Exner
et al, 2012; Martin et al, 2011). In three seminal studies, Pink1
mutant Drosophila displayed mitochondrial abnormalities and
muscle degeneration in a manner highly similar to park mutants,
and Parkin overexpression largely rescued the phenotypes of Pink1
mutants, but not vice versa, suggesting that the two proteins act in a
common linear pathway (Clark et al, 2006; Park et al, 2006; Yang
et al, 2006). Manipulation of the mitochondrial remodeling machinery
rescues some Pink1 and park mutant phenotypes in Drosophila and
in mammalian cell lines. However, while increasing fission rescues
the Drosophila phenotypes, shifting the fusion/fission balance in
the opposite direction rescues mammalian cell lines, but the under-
lying mechanisms are not fully understood (Deng et al, 2008; Poole
et al, 2008; Lutz et al, 2009). PINK1, a mitochondrial Ser/
Thr kinase, and Parkin, an E3 Ubiquitin ligase, were found to
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regulate clearance of damaged mitochondria via mitophagy
(Geisler et al, 2010; Narendra et al, 2010; Vives-Bauza et al, 2010),
and microtubular transport (Weihofen et al, 2009; Wang et al,
2011). However, other studies have reported additional functions of
Parkin in the regulation of stress response proteins and mitochon-
drial biogenesis (Bouman et al, 2011; Shin et al, 2011), in promoting
NF-κB signaling (Henn et al, 2007; Muller-Rischart et al, 2013),
and in controlling cytochrome-c release (Berger et al, 2009). PINK1
also has additional functions, unrelated to recruiting Parkin, such as
regulating mitochondrial calcium buffering (Gandhi et al, 2009;
Sandebring et al, 2009; Heeman et al, 2011). Furthermore, PINK1
mutant mitochondria have decreased activity of complex I of the
ETC (Morais et al, 2009), and overexpression of a yeast substitute
for complex I rescued many of the functional impairments of Pink1
mutant flies (Vilain et al, 2012). Additional studies are required to
elucidate which of the functions reported for Parkin and PINK1 are
critical for causing Parkinson pathology.
The neurotrophic factor Glial cell line-derived neurotrophic
factor (GDNF) promotes the survival of dopamine neurons (Lin
et al, 1993) and protects nigral dopamine neurons from cell death in
rodent and primate toxin-models of PD such as 6-hydroxydopamine
(6-OHDA) and MPTP (Kearns & Gash, 1995; Sauer et al, 1995;
Tomac et al, 1995; Gash et al, 1996). Several clinical trials have
been performed with mixed outcomes, but ongoing research and
development aims at improving delivery methods of GDNF (Deierborg
et al, 2008). GDNF signals via the GPI-anchored co-receptor GFR-a1
and the receptor tyrosine kinase Ret (Airaksinen & Saarma, 2002).
Endogenous Ret expression is required for long-term survival of a
fraction of nigral dopamine neurons in aged mice (Kramer et al,
2007). Conversely, mice that express a constitutively active Ret
receptor in dopamine neurons (RetMEN2B) show increased numbers
of dopamine neurons (Mijatovic et al, 2007). The mechanism by
which GDNF/Ret protects dopamine neurons from cell death is not
fully elucidated. We hypothesized that Ret-activated signaling path-
ways converge with functions of proteins associated with familial
PD. We recently reported that Ret and DJ-1 double loss-of-function in
aged mice exacerbates the neuron loss observed in Ret single
mutants (Aron et al, 2010). Here, we investigated whether Ret inter-
acts genetically with park and Pink1 in Drosophila. We found that
constitutively active RetMEN2B specifically rescues phenotypes of
Pink1 mutants, including muscle degeneration, mitochondrial
morphology and function, whereas parkmutants remained unaffected.
Moreover, Ret signaling rescued mitochondrial morphological and
functional defects of PINK1-deficient human SH-SY5Y cells, without
activating mitophagy. Mechanistically, Ret signaling restored the
activity of complex I of the ETC, which is reduced in Pink1, but not
park mutant flies. Thus our study indicates that Ret signaling can
specifically ameliorate Pink1 loss-of-function deficiencies that are
relevant to human Parkinson’s disease.
Results
Active Ret rescues Pink1 but not park mutant
muscle degeneration
To study whether Ret can modify Pink1 and park phenotypes, we
utilized the Drosophila indirect flight muscles (IFMs) as a model
system. Here, Pink1 and park mutants undergo significant muscle
degeneration, likely because of the high energy consumption of the
IFMs, and display enlarged mitochondria with broken cristae. Late
stage pupae display normal muscle morphology, but soon after eclo-
sion, the muscle tissue degenerates (Greene et al, 2003; Clark et al,
2006; Park et al, 2006). In 3- to 5-day-old Pink1 and park mutant
animals housed at 18°C, interrupted muscles were found, and one
or several of the six muscles displayed degenerated, highly irregular
myofibrils with abnormal sarcomere structure, hereafter referred to
as “degenerated” (Fig 1I and K) in approximately 65% of the
animals as compared to controls, which never displayed this pheno-
type (Fig 1A, B, E, F, L). To investigate whether Ret signaling could
modify muscle degeneration, we utilized the constitutively active ver-
sion, RetMEN2B, which has an activating point mutation in the kinase
domain (M955T) (Read et al, 2005). In an expression analysis of
endogenous Ret by reverse transcriptase PCR (RT-PCR), we detected
high levels of Ret mRNA in larvae and pupae, and lower levels in the
adult thorax and IFMs (Supplementary Fig S1). To achieve robust
overexpression of activated Ret specifically in muscles, we used the
UAS-GAL4 system and the Myocyte enhancer factor-2 (Mef2) GAL4
driver, which is active in all muscle tissues from the early embryo
throughout larval and pupal stages and in the adult fly. Mef2>
RetMEN2B overexpression caused lethality at 25°C, but at 18°C, viable
progeny eclosed with lower frequency. Surviving transgenic flies
displayed mild muscle abnormalities, including deposits of actin
dispersed over the muscle tissue, and some abnormally thick and
irregular myofibrils (Fig 1C, G, J). A recent RNAi screen for modifiers
of muscle development (Schnorrer et al, 2010) identified a large
number of lines with a highly reminiscent phenotypic class and
designated this “actin blobs”, we therefore refer to this by the same
term. When RetMEN2B was overexpressed in the background of Pink1
mutants, the majority of flies showed significantly improved muscle
morphology, with only 12% of flies displaying degenerated
myofibrils (Fig 1D and L). The frequency of flies with actin blobs
also decreased markedly compared to RetMEN2B expressing controls,
suggesting that Pink1 function may be required for this phenotype.
However, in contrast to Pink1 mutants, park mutants overexpressing
RetMEN2B showed no improvement as the frequency of degenerated
myofibrils remained unchanged (Fig 1H and L). Expression of the
RetMEN2B protein was examined by Western Blot of thorax homogen-
ates and levels were similar between the Pink1 and park mutants,
indicating that differences in transgene expression were not a likely
cause of the differential response (Fig 1M). To determine if Ret pro-
tein expression or Ret signaling was required for the phenotypic res-
cue, we overexpressed wild-type (WT) Ret using the same GAL4
driver. We found that RetWT was unable to modify the phenotype
probably because the putative Ret ligand was not present in the
IFMs at significant levels at this stage (Supplementary Fig S2).
Moreover, the effects of Ret on IFM morphology appeared rather
specific, since overexpression of a constitutively active fibroblast
growth factor receptor (FGFR), UAS-htlk, caused a dramatic change
in IFM fate (data not shown).
Rescue of Pink1 mutants is not developmental
The partial embryonic lethality and appearance of actin blobs by
Mef2>RetMEN2B overexpression indicated that high levels of Ret
signaling interfered with normal muscle development. Other receptor
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Figure 1. RetMEN2B overexpression rescues Pink1 but not park mutant muscle degeneration.
A–K Drosophila hemi-thoraces stained with phalloidin at low magnification (upper panels) showing overall indirect flight muscle (IFM) morphology, and at higher
magnification (lower panels). High-magnification images of WT sarcomeres (I), sarcomeres with ‘actin blobs’ (J), and degenerated sarcomeres (K).
Heterozygous controls (A, E) display normal IFM layout (upper panels), myofibril morphology (lower panels) and sarcomeres (I). Pink1 (B) and park mutants (F)
display abnormal morphologies with truncated muscles (yellow arrow heads, upper panels) and disorganized myofibrils (lower panels) with degenerated
sarcomere structure (K). Animals overexpressing RetMEN2B (C, G) display normal IFM layout (upper panels), fairly normal myofibril morphology with occasional
deposits of mislocated actin filaments, and actin blobs, (red arrow heads, lower panels and J). RetMEN2B overexpression in Pink1 mutants largely rescues the
mutant phenotypes, as the majority of animals display normal IFM morphology (D), while park mutants are not rescued (H).
L Percentage of flies with phenotype “wild type” (blue), “actin blobs” (green), “degenerated” (red) or “actin blobs and degenerated” (yellow).
M Western blot analysis of Ret expression in thorax homogenates from w1118 controls, and Pink1, or park mutants overexpressing RetMEN2B, indicating similar levels
of Ret overexpression between the two mutant backgrounds. Tissue from three animals per sample. Tubulin was used as a loading control.
N–U Overexpression of UAS-RetMEN2B under control of Mhc-GAL4 and Tub-GAL80ts, pupae were shifted from 18 to 30°C at pupal stage 11, activating expression after
muscle formation is completed. Heterozygous controls (N, R) and RetMEN2B late overexpressing animals display normal muscle and myofibril morphologies
(N, P, R, S, T). Pink1 (O) and park mutants (S) display abnormal morphologies with truncated muscles and disorganized myofibrils with degenerated sarcomere
structure (lower panels). Late RetMEN2B overexpression in Pink1 mutants (Q) largely rescues the mutant phenotypes, while park mutants (U) are not rescued.
V Percentage of flies with phenotype “wild type” (blue) or “degenerated” (red). Number of animals per genotype as depicted in figure.
Data information: Scale bars: upper panels, 100 lm; lower panels, 10 lm.
Source data are available online for this figure
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tyrosine kinases such as epidermal growth factor receptor (EGFR)
and FGFR are known to regulate embryonic myoblast specification
via Ras/Erk signaling (Carmena et al, 1998; Halfon et al, 2000), and
the insulin receptor controls muscle size (Demontis & Perrimon,
2009). Therefore, it is plausible that active RetMEN2B affects these, or
similar developmental processes. To verify that the rescue of the
Pink1 mutants is not a developmental interaction, we utilized the
GAL80ts system which permits transgene expression in a defined
time window regulated by temperature. To drive RetMEN2B expres-
sion, we chose the GAL4 driver, Myosin heavy chain (Mhc) GAL4,
which expresses only in differentiated muscles, not in myoblasts, in
difference to Mef-GAL4 and generates higher expression. Unlike
Mef2-GAL4, it causes complete lethality when driving RetMEN2B from
embryonic stages. Flies were crossed at 18°C (non-permissive
temperature), after which pupae were shifted to 30°C (permissive
temperature) at pharate adult stage P11  3 h (equivalent of 75 h
APF at 25°C) (Flybase FBdv:00005349), a time well after completion
of IFM development, but before the onset of apoptotic degeneration
in Pink1 and park mutants (Greene et al, 2003; Clark et al, 2006).
Analyses were again performed at 3–5 days post-eclosion. Using this
protocol, Pink1 and park mutants showed degenerated myofibrils
with a frequency of approximately 90% and 80% respectively as
compared to controls (Fig 1N, O, R, S, V), the higher penetrance being
likely due to the increased temperature. RetMEN2B-overexpressing
flies eclosed with Mendelian frequencies and displayed fully normal
muscle morphology, without the presence of actin blobs, confirming
the hypothesis that the lethality and actin blob phenotypes have
developmental origins (Fig 1P, T, V). When RetMEN2B was expressed
in Pink1mutants from this late pupal stage and onwards, it again lar-
gely rescued muscle degeneration, indicating that the rescue is not
due to a developmental interaction, but a direct protective effect of
Ret signaling on degenerating tissue (Fig 1Q and V). Interestingly,
park mutants were again not rescued using this expression protocol
(Fig 1U and V).
Ret signaling rescues mitochondrial morphology in flight muscles
One possibility is that RetMEN2B inhibits muscle degeneration without
directly targeting the primary cause of the Pink1 phenotype: mito-
chondrial impairments (Clark et al, 2006). To test this possibility,
we analyzed the ultrastructure of mitochondria using transmission
electron microscopy. IFMs from control flies showed regular
organization of myofibrils and densely packed mitochondria with
intact cristae (Fig 2A, E, L, M). Pink1 and park mutants displayed a
heterogeneous population of mitochondria with the majority having
significantly enlarged sizes and mild or severe disruption of their
cristae structure, when compared to control mitochondria (Fig 2B,
F, I-M). Mef2>RetMEN2B overexpression in control flies did not alter
normal mitochondria morphology (Fig 2C, G, L, M). However, in
Pink1 mutants, RetMEN2B overexpression significantly reduced the
fraction of severely impaired mitochondria and increased the
fraction of mitochondria with WT-like cristae structure (Fig 2D and L).
In contrast, park mutants showed no improvement of structural
impairments when RetMEN2B was overexpressed (Fig 2H and M).







Figure 2. RetMEN2B rescues mitochondrial cristae structure of Pink1 mutants.
A–K Transmission electron microscopy images of indirect flight muscles. Heterozygous controls (A, E) and animals overexpressing RetMEN2B (B, F) display normal
mitochondria of similar size with highly dense cristae structure. Pink1 and park mutants have enlarged mitochondria with broken cristae (C, G). Phenotype can
vary from mild to severe. High-power images of mitochondria are shown for the categories wild type (I), mild (J), severe phenotype (K). RetMEN2B overexpression
partially restores mitochondrial size and cristae structure in Pink1 (D), but not park mutants (H). Scale bar, 2 lm.
L, M Percentages of mitochondria of the indicated categories, 500–800 mitochondria per animal, averages of 6 animals per genotype.
The EMBO Journal Ret signaling rescues Drosophila Pink1 mutants Pontus Klein et al
The EMBO Journal Vol 33 | No 4 | 2014 ª 2014 The Authors344
These results demonstrate that RetMEN2B can rescue mitochondrial
impairments of pink1 but not park mutants, suggesting that the
mitochondrial deficiencies of the two mutant strains have partially
different origins.
Ret rescues mitochondrial morphology in dopaminergic neurons
To address whether RetMEN2B also rescues the morphology of mito-
chondria in dopaminergic neurons, we overexpressed RetMEN2B
using TH-GAL4 together with the mitochondrial marker mitoGFP
(Pilling et al, 2006). Pink1 and park mutants displayed severely
enlarged mitochondria as compared to controls (Fig 3A, B, E, F, I, J).
RetMEN2B overexpression in a control background did not signifi-
cantly alter the normal mitochondrial background (Fig 3C, G, I, J).
However, when overexpressed in Pink1 mutants, mitochondrial size
was significantly rescued (Fig 3D and I). Quantification of mito-
chondrial volumes revealed that in the presence of RetMEN2B the
abundance of normal mitochondria was increased, while the frac-
tion of enlarged mitochondria decreased to levels similar to those of
control flies. Merely, the 4% largest mitochondria were not rescued.
In line with the analysis of mitochondria in muscle, mitochondrial
morphology in neurons of park mutants was not rescued by
RetMEN2B (Fig 3H and J).
GDNF/Ret signaling rescues mitochondrial defects in
mammalian cells
In order to assess whether signaling from endogenous Ret can also
rescue mitochondrial impairments caused by loss of PINK1 function,
we used the human dopaminergic neuroblastoma cell line SH-SY5Y,
which expresses endogenous Ret. Acute knock-down of PINK1 in
this cell line was previously shown to cause fragmentation of the
mitochondrial network (Lutz et al, 2009) (Fig 4A, B, D). Stimulation
of Ret by GDNF and soluble GFRa-1 rescued mitochondrial fragmen-
tation, demonstrating that endogenous mammalian Ret can rescue
mitochondrial impairments (Fig 4C and D). A semi-quantitative
RT-PCR analysis of PINK1 mRNA controlled that GDNF/GFRa-1
stimulation did not upregulate PINK1 levels (Fig 4E).
Ret rescues mitochondrial morphology independently of
Parkin-induced mitophagy
Although the data so far suggested that Ret rescues Pink1-deficient
mitochondria independently of Parkin, we cannot exclude that Ret
signaling activates Parkin translocation to mitochondria, thus pro-
moting their clearance through mitophagy. To test this hypothesis,
we treated SH-SY5Y cells overexpressing Parkin with carbonyl
cyanide m-chlorophenyl hydrazone (CCCP) to depolarizemitochondria.
CCCP treatment induced recruitment of Parkin to mitochondria
(detected 2 h after adding CCCP) followed by the removal of depo-
larized mitochondria in about 50% of Parkin-expressing SH-SY5Y
cells (monitored 24 h later) (Fig 4G and N). Parkin-induced
mitophagy required the presence of PINK1, as described previously
(Geisler et al, 2010; Narendra et al, 2010; Vives-Bauza et al, 2010),
but was not impaired in cells silenced for Ret expression (Fig 4H,
I, J, N, O). Moreover, the overexpression of constitutively active
RetMEN2A did not induce Parkin translocation or mitophagy under
any condition, including PINK1 knock-down with or without
Parkin overexpression (Fig 4K, L, M, N). Similar results were
obtained when GDNF and soluble GFRa-1 was used to activate sig-
naling via endogenous Ret (Fig 4N). Furthermore, GDNF/GFRa-1
treatment also rescued mitochondrial fragmentation induced by
PINK1 silencing HeLa cells, a cell type which does not express
endogenous Parkin (Denison et al, 2003; Pawlyk et al, 2003), fur-
ther indicating that Ret signaling rescues PINK1 loss-of-function
phenotypes independently of Parkin (Supplementary Fig S3).
Ret signaling rescues impaired bioenergetics of
Pink1-deficient cells
It has been reported previously that PINK1 deficiency impairs mito-
chondrial respiration (Gautier et al, 2008, 2012; Gandhi et al, 2009;
Lutz et al, 2009; Morais et al, 2009). We therefore investigated
whether activation of Ret signaling via GDNF/GFRa-1 treatment
could influence this phenotype. We measured mitochondrial func-
tion under basal and stress conditions in SH-SY5Y cells silenced for
PINK1 expression by using an extracellular oxygen flux analyzer. In
comparison to control siRNA-treated cells, PINK1-deficient cells
were characterized by a decreased oxygen consumption rate even
under basal conditions (Fig 5A). Moreover, the spare respiratory
capacity (difference between maximal and basal respiration) was
markedly reduced, indicating that the ability of PINK1-deficient cells
to respond to an increased energy demand under stress conditions
is severely impaired. Remarkably, GDNF/GFRa-1 treatment fully
rescued basal respiration and increased maximal respiration in
PINK1-deficient cells, indicating that the beneficial effect of
increased Ret signaling in PINK1-deficient models can be explained
by influencing the bioenergetic capacity of mitochondria rather than
mitophagy.
Complex I deficiency of Pink1 mutants rescued by Ret signaling
To investigate whether Ret signaling also rescued mitochondrial
functionality in Drosophila, we measured ATP content of thoracic
homogenates. As previously shown (Clark et al, 2006; Park et al,
2006; Yang et al, 2006; Vos et al, 2012), Pink1 and park mutants
showed reduced ATP content in the thorax to approximately 40% of
controls, including flies carrying the Mef2-GAL4 driver (Fig 5B and C).
Mef2 > RetMEN2B overexpression in control flies caused a slight
reduction in ATP as compared to controls, possibly as a result of
their mild muscle phenotype. In line with the rescue of myofibril and
mitochondrial structures, RetMEN2B overexpression largely rescued
ATP levels in Pink1 mutants, while ATP levels of park mutants did
not significantly improve (Fig 5B and C). To unravel the underlying
mechanism of the improved mitochondrial respiration, we
turned our attention to complex I of the ETC. Recent reports had
found that Pink1, in contrast to park mutants had decreased activity
of the ETC, and specifically of complex I function (Morais et al,
2009; Vilain et al, 2012). For these reasons, we measured complex I
activity in RetMEN2B-overexpressing Pink1 mutants, by monitoring
rotenone-sensitive NADH oxidation by spectrophotometry, normal-
ized to the activity of citrate synthase. As previously observed,
Pink1 mutants displayed markedly reduced complex I activity
(Fig 5D). Interestingly, RetMEN2B significantly increased complex I
activity to levels similar to controls (Fig 5D). In accordance with pre-
viously reported data, park mutants showed no decreased complex I
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Figure 3. Rescue of Pink1 mutant dopamine neuron mitochondria by RetMEN2B.
A–H Confocal maximum projections (left panels) and isosurface renderings (right panels) of dopamine neuron mitochondria in the PPL1 cluster of dopaminergic
neurons, visualized by mitoGFP and immunostainings against GFP and TH. Genotypes: All flies contain TH-GAL4 and UAS-mitoGFP and Pink1, park mutant alleles,
as well as UAS-RetMEN2B as indicated. Isosurface renderings are color-coded according to volume from 0 to 3 lm3. RetMEN2B-overexpressing control animals (C, G)
display normal mitochondrial morphology as compared to non-transgenic controls (A, E). Pink1 mutants (B) and park mutants (F) display severely enlarged
mitochondria, and RetMEN2B partially rescues mitochondrial size in Pink1 mutants (D), but not in park mutants (H). Scale bar, 5 lm.
I, J Mitochondrial volume distributions of (A–D) and (E–H) in categories as indicated. Due to differences in staining and imaging conditions, data between the Pink1
and park datasets cannot be directly compared. n = 8–20 animals per genotype.
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activity as compared to controls (Fig 5E). Depleting the complex I
subunit (CG11455) from muscles by RNAi abrogated most complex I
activity (Fig 5F), and RetMEN2B overexpression was not able to res-
cue this defect (Fig 5F), suggesting that Ret signaling does not acti-
vate alternative means of NADH oxidation as previously shown for
the yeast protein Ndi1p (Vilain et al, 2012). The mechanism by
which Pink1 controls complex I function is still unknown. Drosoph-
ila complex I contains 48 subunits, six of which are mitochondrially
encoded, the rest being nuclear. The supply of commercially avail-
able antibodies for Drosophila complex I is limited to the subunit
NDUFS3, which has recently been shown to be reduced in Pink1
mutants (Liu et al, 2011). By Western blot, we could confirm the
reduction of NDUFS3, but did not observe an upregulation by
RetMEN2B (Supplementary Fig S4A and B). We performed a semi-
quantitative RT-PCR screen of other complex I subunits in Pink1
mutants compared to RetMEN2B-overexpressing Pink1 mutants. Of 45
subunits analyzed, most were unchanged, but the transcript of
CG6485, orthologous to human NDUFV2, was moderately elevated
in RetMEN2B-overexpressing Pink1 mutants (Supplementary Fig S4C).
Interestingly, when compared to controls, CG6485 mRNA was
reduced by 46% in Pink1 mutants, and significantly increased to
117% of controls by RetMEN2B overexpression (Fig 5G and H). This
effect may at least in part be responsible for the Ret-mediated rescue
of Pink1 deficiency.
Discussion
The receptor tyrosine kinase Ret is already known to be required for
long-term survival of nigral dopamine neurons in mice, and stimula-
tion with its ligand GDNF protects dopamine neurons from cell
death in a variety of toxin-based rodent and primate models of PD.
In the present work, we found that a signaling-active version of the
Drosophila homolog of Ret suppresses degeneration of muscle tissue
and mitochondrial abnormalities in Pink1 mutants. Interestingly,
park mutants were not rescued. In human SH-SY5Y cells, stimula-
tion of endogenous Ret by GDNF rescued both morphological and
bioenergetic defects of mitochondria in PINK1-depleted cells. Pink1
and Parkin were previously shown to interact genetically in Dro-
sophila in what was proposed to be a linear pathway, and a signifi-
cant body of work has described how Pink1 and Parkin function to
initiate mitophagy of impaired mitochondria, and arrest of mito-
chondrial trafficking. However, in our cell culture model, Ret signal-
ing did not induce mitophagy or Parkin recruitment, arguing that
Ret rescues PINK1 deficits independently of Parkin. A recent study
demonstrated that Pink1 mutants in contrast to park mutants have
decreased function of complex I of the electron transport chain, sug-
gesting that Pink1 is required for maintaining efficient complex I
enzymatic activity and that this function is upstream of mitochon-
drial remodeling. We found that Ret rescued both the impairment of
complex I activity, and partially the mitochondrial morphology in
Pink1 mutants, suggesting that complex I is a target of Ret signaling.
Previous studies of complex I inhibition or genetic depletion have
shown mild morphological impairments in Drosophila muscle, con-
trary to the stronger phenotype of Pink1 mutants. Therefore, it was
somewhat unexpected that restoring complex I activity would be
sufficient to rescue also morphological defects. One interpretation is
that the Pink1 mutant morphological phenotype is more severe due
to a synergistic effect of deficits in remodeling/mitophagy and com-
plex I activity, which in this study was partially rescued. Another
possibility is that Ret signaling not only targets complex I, but also
morphology in a Parkin-independent manner.
Extrapolated to mammalian models, our results suggest a novel
mechanism by which the GDNF family of neurotrophic factors may
promote survival of dopamine neurons in PD. Several of the mam-
malian models where the neuroprotective effects of GDNF treatment
were initially discovered, were in fact models of mitochondrial dys-
function, either directly via complex I inhibition by MPTP treatment
(Tomac et al, 1995; Gash et al, 1996), or the more general ROS
toxicity of 6-OHDA (Kearns & Gash, 1995; Sauer et al, 1995), which
also includes complex I impairments (Glinka et al, 1997). In light of
our findings, it would be interesting to investigate whether or not
GDNF improves complex I activity in these model systems. GDNF
has been tested in models of alpha-synuclein overexpression, a
pathology that is not known to cause complex I deficiency, but did
not show any neuroprotective effects, fitting with our hypothesis
(Lo Bianco et al, 2004; Decressac et al, 2011).
The current findings support recent evidence showing that Pink1
has an important function related to complex I activity, which is inde-
pendent of its function in recruiting Parkin to the outer mitochondrial
membrane upon loss of membrane potential. This model is consistent
with a partial rescue of Pink1 deficiencies, e.g. by either overexpress-
ing Parkin or the yeast complex I equivalent NADH dehydrogenase,
or, in the current work, RetMEN2B (Clark et al, 2006; Park et al, 2006;
Yang et al, 2006; Vilain et al, 2012). In addition, our findings are con-
sistent with a recent study showing that Pink1-deficient flies but not
Parkin-deficient flies can be rescued by TRAP1, which also seems to
have beneficial effects on complex I activity (Zhang et al, 2013).
The pathways by which Ret signaling targets complex I and
rescues Pink1 mutants requires further investigation. Also, the
mechanism by which Pink1 regulates complex I remains elusive, it
may regulate for example gene expression, phosphorylation status
or assembly (Salvi et al, 2005; Pagliarini & Dixon, 2006) (Fig 6).
Our gene expression analysis showed that most subunits are
unchanged by RetMEN2B, but interestingly one subunit was moderately
downregulated in Pink1 mutants and upregulated by RetMEN2B,
which may improve function. However, we do not exclude the
possibility that Ret signaling targets complex I, and perhaps other
metabolic components, by different means.
Brain-derived neurotrophic factor (BDNF) protects mouse cortical
neurons against drug-induced excitotoxicity, an effect that was
blocked by the complex I inhibitor Rotenone and a MEK1/2 inhibitor,
suggesting that BDNF signaling via the Ras/Erk pathway can
regulate complex I function (Markham et al, 2012). The signaling
properties and functions of Drosophila Ret are not characterized in
great detail, but it is structurally homologous to mammalian Ret and
can, to some extent, activate the same signaling pathways (Abrescia
et al, 2005). Mammalian Ret on the other hand, has been exten-
sively characterized and is known to activate a number of down-
stream signaling pathways including Ras/ERK, phosphoinositol-3
kinase (PI3K)/Akt, phospholipase C-gamma (PLCγ), Janus kinase
(JAK)/STAT, and ERK5, several of which have pro-survival effects,
most notably the PI3K/Akt pathway (Sariola & Saarma, 2003;
Pascual et al, 2011). Recent studies of Pink1 and park mutant
Drosophila have indicated that PI3K/Akt signaling or components
downstream of this pathway rather exacerbates Pink1 and park
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mutant phenotypes (Tain et al, 2009; Liu & Lu, 2010), making it an
unlikely candidate for rescue.
Additional studies are required to elucidate the details by which
Pink1 and Ret regulate complex I activity, and whether this finding
is transferrable to mammalian models. In summary, this work
shows that Ret signaling can rescue phenotypes of Pink1 mutants
by restoring mitochondrial respiration and specifically complex I
function, and thereby suggests a potential novel mechanism under-
lying GDNF-mediated protection in mammalian PD models. In the
future, screening of PD patients for complex I deficiencies and
subjecting specifically those individuals to GDNF treatment may
provide a new therapeutic strategy.
Materials and Methods
Fly strains and procedures
Mef2-GAL4;UAS-RetMEN2B is lethal at 25°C, therefore all crosses were
performed at 18°C. All analyses were performed with 2- to 5-day-old
flies. In experiments with Mhc-GAL4;Tub-GAL80ts, pupae were shifted
from 18 to 30°C at pharate adult stages P11-P12 (Flybase
FBdv:00005349) and analyzed at 3–4 days post eclosion. park25
(Greene et al, 2003) was provided by Leo Pallanck, park1 (Cha et al,
2005) and Pink1B9 (Park et al, 2006) were provided by Jongkyeong
Chung, Pink1B9::Mef2-GAL4 (Tain et al, 2009) was provided by Alex
Whitworth, UAS-RetMEN2B (Read et al, 2005) was provided by Ross Ca-
gan, TH-GAL4 (Friggi-Grelin et al, 2003), was provided by Hiromu
Tanimoto, Mef2-GAL4 (Ranganayakulu et al, 1996), Tub-GAL80ts
(McGuire et al, 2003), and UAS-mitoGFP (Pilling et al, 2006) were
obtained from the Bloomington stock center, UAS-CG11455RNAi
(#12838) was obtained from Vienna Drosophila RNAi Center. “+” con-
trols depict Pink1 and parkWT alleles from w1118 (Bloomington stock
#5905). In For all histology experiments, flies were genotyped by PCR
to assure correct genotypes and control for X-chromosome non-dis-
junction, for list of primers see Supplementary information.
Myosin heavy chain – GAL4 flies
A 2.5 kb Mhc enhancer was amplified from genomic DNA using
primers FS124 (5′-tcaggtaccGGCCGCTCTAGAAATGATATGTG-3′)
and FS125 (5′-tcacgcggccgcATTATCCTTGCTTAAATTTCGTTTAG-
3′) and cloned with Asp718/NotI into a GAL4-containing
Casper-based P-element transformation vector. Transgenic flies
were generated using standard procedures. In contrast to the
formerly published GAL4 line (Schuster et al, 1996), which shows a
rather weak activity in embryos, larvae and adults, this new Mhc-
GAL4 line is very strong and very specifically expressed in differenti-
ated muscles from embryonic stages onwards (FS, unpublished).
Histology, transmission electron microscopy and analysis of
mitochondrial morphology
Hemi-thoraces were prepared as described previously (Schnorrer
et al, 2010), stained with Phalloidin-Alexa Fluor-568 (Molecular
Probes), and single plane images were acquired on an Olympus
FV1000 confocal scanning microscope. For transmission electron
microscopy, hemi-thoraces were fixed in 2.5% Glutaraldehyde, from
which semithin sections were prepared and stained with toluidine-
blue, subsequently ultrathin serial sections were prepared using a Le-
ica EM UC6 Ultramicrotome. Images at 5,000× magnification were
acquired using a JEOL JEM-1230 transmission electron microscope
at 80 kV, equipped with a Gatan Orius SC1000 digital Camera. Six
TEM Images per animal were acquired from randomly selected
regions of the indirect flight muscles. All mitochondria in these
images (500–800 per animal) were grouped into three categories,
based on the integrity of the cristae structure, with genotypes blinded
to the experimenter, using the ImageJ software (NIH). Whole mount
immunostaining of fly brains was performed according to standard
procedures. The following antibodies were used: rabbit anti-tyrosine
hydroxylase (ab152, Millipore; 1:200) and chick anti-GFP (Abcam
ab13970; 1:500). The PPL1 cluster was imaged using an Olympus
FV1000 confocal microscope with a 60× NA 1.3 objective with 4×
zoom. 52 z-sections of 0.3 lm spacing were acquired and decon-
volved by the nearest neighbor algorithm using Metamorph 7.5
(Molecular Devices). A volume corresponding to 26 × 26 × 15 lm
was cropped, subjected to linear rescaling and analyzed in Imaris x64
6.4.2 (Bitplane Scientific Software). Mitochondrial volume was mea-
sured by 3D isosurface rendering using a fixed threshold.
Immunoblot analysis
Thoraces from three animals per sample were homogenized in
Triton-lysis buffer, protein concentration was determined using the
BCA method (BioRad), equal amounts of protein were separated
using SDS-PAGE and blotted according to standard procedures.
◂ Figure 4. Activation of Ret signaling mammalian cells rescues PINK1 deficiency, but has no effect on mitophagy.A–C SH-SY5Y cells expressing endogenous Ret, transfected with scrambled control siRNA (A) display normal tubular mitochondrial morphology, visualized by
immunostaining for TOM20 (white); DAPI (blue) indicates nuclei. Cells silenced for PINK1 expression display increased mitochondrial fragmentation (B).
Stimulation of Ret signaling by treatment of cells with GDNF together with soluble GFRa-1 rescues mitochondrial fragmentation after PINK1 knockdown (C).
D Quantification of cells with either tubular (gray) or fragmented (blue) mitochondria.
E Quantification of PINK1 mRNA by quantitative RT-PCR indicates that GDNF/GFRa-1 treatment has no effect on PINK1 expression.
F–M SH-SY5Y cells were treated with CCCP for 2 or 24 h to depolarize mitochondria, and then stained for HSP60 (red), DAPI (blue) and Parkin or Ret (green) as
indicated. Cells with endogenous Parkin expression display low levels of mitophagy (F) and no cells fully cleared of mitochondria were detected 24 h after CCCP
treatment. Cells overexpressing Parkin display translocation of Parkin to mitochondria 2 h after CCCP treatment and complete clearance of mitochondria by 24 h
after adding CCCP (G). White arrowheads indicate cells without detectable mitochondria. Silencing of PINK1 by siRNA largely inhibits Parkin translocation and
mitophagy (H), whereas silencing of Ret has no effect on mitophagy alone (I) or in cells overexpressing Parkin (J). Overexpression of constitutively active RetMEN2A
does not activate mitophagy in control or PINK1-silenced cells (K, L), and does not modulate Parkin translocation or mitophagy in Parkin-overexpressing cells (M).
N Quantification of the experiments described in (F–M).
O Quantification of mRNA after PINK1 or Ret silencing by quantitative RT-PCR.
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Figure 5. Ret signaling rescues mitochondrial respiration and complex I function in PINK1-deficient cells.
A Oxygen consumption rate in SH-SY5Y cells determined by an extracellular flux analyzer. 1: Injection of the F1FO–ATPase inhibitor oligomycin; 2: injection of the
uncoupler FCCP; 3: injection of the complex I inhibitor rotenone and the and complex III inhibitor antimycin A. Under basal conditions, as well as FCCP-evoked
maximum respiration, PINK1 knockdown cells (red squares) displayed markedly reduced oxygen consumption as compared to controls (green circles). Treatment
of PINK1 knockdown cells with GDNF/GFRa-1 rescued basal respiration and increased FCCP-evoked respiration (open squares).
B, C Relative ATP content in the thorax, normalized by total protein, expressed as percentage of w1118 controls. Pink1 and park mutants have reduced ATP amounts.
RetMEN2B overexpression partially rescues ATP deficiency in Pink1 (B), but not park mutants (C). Averages of 6–12 animals per genotype.
D–F Activity of Complex I (rotenone sensitive), normalized to citrate synthase activity, percentage of heterozygous controls. Pink1 mutants have impaired complex I
function, which is rescued by RetMEN2B overexpression (D). park mutants have normal complex I activity as compared to controls (E). Inactivation of the complex I
subunit CG11455 by RNAi driven by Mef2-GAL4 causes dramatically reduced complex I activity as compared to controls (F) and this was not rescued by RetMEN2B
overexpression.
G Semi quantitative RT-PCR analysis of complex I subunit CG6485 indicates upregulation by RetMEN2B overexpression in Pink1 mutants, GAPDH was used as a
loading control.
H Quantification of CG6485 mRNA normalized to GAPDH, averages of 3 experiments, RNA from 3 thoraces per sample.
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Antibodies used were: panRet (provided by C. Ibanez) and alpha-
Tubulin (clone DM1A, Sigma).
Cell culture, treatments and RNA Interference
SH-SY5Y (DSMZ number ACC 209) cells were cultivated as
described previously (Henn et al, 2005; Schlehe et al, 2008). For
acute stimulation of Ret, cells were incubated for 3–4 h
with recombinant hGDNF (Shenandoah Biotechnology Inc.) and
hGFRa-1 (R&D Systems) at a final concentration of 100 ng/mL.
PINK1 and Ret gene silencing was performed with the following
stealth siRNA oligos (Invitrogen) using Lipofectamine RNAiMAX
(Invitrogen): PINK1 human HSS127945 (SH-SY5Y), Ret human
HSS109181.
Assessment of mitochondrial morphology
SH-SY5Y: Cells grown on 15-mm glass coverslips were fixed with
3.7% PFA in PBS for 10 min. Cells were permeabilized with
0.1% Triton X-100 in PBS for 5 min and blocked with 5% BSA
in PBS at room temperature. Fixed cells were sequentially incu-
bated with primary antibody diluted in blocking solution (TOM20
pAb, overnight at 4°C) and secondary antibody diluted in block-
ing buffer (goat anti rabbit Alexa555- coniugated, 2 h at room
temperature). Nuclei were counterstained with DAPI. Coverslips
were mounted on glass slides and images were acquired with a
Zeiss LSM710 confocal microscope equipped with a 63× oil
objective (NA 1.4). Cells displaying an intact network of tubular
mitochondria were classified as tubular. When this network was
disrupted and mitochondria appeared either globular or rod-like
they were classified as fragmented. The mitochondrial morphol-
ogy of the cells was determined in a blinded manner. Quantifi-
cations were based on 150 cells from at least 3 independent
experiments.
Assessment of mitophagy
SH-SY5Y cells were plated on glass coverslips and reversely trans-
fected with siRNA and 24 h later with the indicated DNA
plasmid. Human GDNF and GFRalpha were added to the cells 24 h
after siRNA transfection and 3 h before CCCP treatment. The
next day, cells were treated with 10 lM carbonyl cyanide
3-chlorophenylhydrazone (CCCP, Sigma) for 2 or 24 h. Recruitment
of parkin to mitochondria (after 2 h CCCP) and removal of
mitochondria (after 24 h CCCP) was detected by indirect immuno-
fluorescence using a monoclonal anti-Parkin antibody (PRK8, Santa
Cruz Biotechnology) and a polyclonal antibody against HSP60






























Figure 6. Model of Pink1 and RetMEN2B functions.
Our results suggest a dual role for Pink1: One in recruiting Parkin to themitochondria and initiating mitochondrial clearance or regulating mitochondrial trafficking, a second
in regulating the activity of complex I via an as yet unclear pathway. This could be mediated, for example, via phosphorylation of the protein complex or by regulating
expression of complex I components. Loss of Pink1 decreases complex I activity and respiratory function. Ret rescues specifically Pink1 mutants, by restoring complex I
activity, respiration and ATP production, in part by upregulating the mRNA levels of the complex I subunit NDUFV2 (CG6485).
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were analysed by fluorescence microscopy using a Leica DMRB
microscope and confocal images were taken using a Zeiss LSM710
confocal microscope equipped with a 63× oil objective (NA 1.4).
Quantifications are based on three independent experiments. At
least 1,500 cells were analysed for each condition.
Real-time RT-PCR, cultured cells
Knock-down efficiency of PINK1 and Ret was evaluated by real-time
RT-PCR with the 7500 Fast Real Time System (Applied Biosystems)
as previosly described (Bouman et al, 2011). Statistical analysis
of RT-PCR data is based on at least four independent experiments
with triplicate samples. For list of primers, see Supplementary
information.
Measurement of mitochondrial oxygen consumption
The oxygen consumption rate was determined using a Seahorse XF
96 analyzer (Seahorse Biosciences). SH-SY5Y cells were reversely
transfected and plated in a XF 96 cell culture microplate. The next
day, fresh medium containing human GDNF/GFRa-1 was added to
the cells where indicated. The cells were incubated with low-glucose
(1 mM) medium overnight and the sensor cartridge was hydrated
overnight according to the manufacturers’ instructions. Measure-
ments were performed 48 h after transfection. The measured values
were normalized to protein levels. PINK1 knockdown did not induce
apoptosis under these conditions. The cells were washed using the
XF Prep Station three times with Seahorse Medium containing
10 mM galactose and 1 mM pyruvate. Mitochondrial function was
analyzed using the XF Cell Mito Stress Test Kit (Seahorse Biosciences)
and all measurements were carried out at 37°C. The following drugs
were diluted in Seahorse Medium and loaded on the sensor
cartridge: oligomycin (injection port A), carbonyl cyanide p-(triflu-
oromethoxy)phenylhydrazone (FCCP; injection port B), rotenone
and antimycin A (both injection port C). The drugs were diluted in
Seahorse Medium and loaded on the sensor cartridge. Measured
values were normalized to protein levels.
ATP measurement
Measurements of thoracic ATP were performed using a luciferase
assay as described previously (Park et al, 2006) with some modifi-
cations: Briefly, single thoraces from 3-day-old flies with heads
and wings removed were homogenized in 50 ll of extraction
buffer (100 mM Tris-HCl, 4 mM EDTA pH 7.8) with 6 M Guani-
dine-HCl using a teflon-on-glass dounce homogenizer. The lysate
was boiled for 3 min and cleared by centrifugation at 20,000 g for
1 min. The samples were diluted 1:100 in extraction buffer before
analyzing using the ATP determination kit (Invitrogen), according
to the manufacturer’s instruction. Values were normalized to total
protein content, measured by absorbance at 280 nm using a
NanoDrop spectrophotometer. All measurements were performed
in triplicate.
Enzymatic measurements
Activity of complex I (NADH: ubiquinone oxidoreductase) was
assessed by monitoring the oxidation of NADH as previously
described (Fischer et al, 1986). Briefly, thoraces from 20 animals
were homogenized in 250 mM sucrose, 10 mM Tris pH 7.4,
0.15 mM MgCl2, after which mitochondria were isolated as
described previously (Walker et al, 2006). Enzymatic activity of
complex I was assessed by NADH oxidation, monitored at
A340 nm as described (Bugiani et al, 2004), and rotenone insensi-
tive activity was subtracted. The activity of complex I was normal-
ized to Citrate Synthase activity, which was measured indirectly
by AcCoA-SH formation, as described (Ferguson & Williams,
1966).
RT-PCR, Drosophila complex I subunits
Thoraces were dissected and snap-frozen, homogenized in RLT
buffer (Qiagen) using a rotor-stator homogenizer. Total RNA was
prepared using the RNeasy mini kit according to instructions. Samples
were treated with DNase1 on-column for 15 min (RNase-free DNase
set, Qiagen). RT-PCR analysis was performed using the OneStep
RT-PCR kit (Qiagen) using 20 ng of template RNA and 35–40 cycles
of PCR amplification depending on signal strength of the primer
pair. Primers were designed using the primerBLAST tool (NCBI),
and when possible exon-junction spanning primers were used, for
list of primers, see Supplementary information. As some of the
analyzed transcripts are single-exon, control reactions omitting the
reverse transcriptase amplification step were performed to assure
that samples were free of contaminating genomic DNA, despite
DNase1 treatment.
Statistical analysis
Data represent mean  SEM. Statistical analysis was carried out
using analysis of variance (ANOVA) or Student’s t-test; *P ≤ 0.05;
**P ≤ 0.01; ***P ≤ 0.001.
Supplementary information for this article is available online:
http://emboj.embopress.org
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